These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21525578)

  • 21. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-transfusion-transmitted hepatitis C virus infection: a study on thalassemia and hemodialysis patients in southeastern Iran.
    Hassanshahi G; Arababadi MK; Assar S; Hakimi H; Karimabad MN; Abedinzadeh M; Rafatpanah H; Derakhshan R
    Arch Virol; 2011 Jul; 156(7):1111-5. PubMed ID: 21340738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of dialysis type on biomarkers for cardiovascular diseases.
    Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R
    Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
    J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
    González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
    Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes.
    Memoli B; Minutolo R; Bisesti V; Postiglione L; Conti A; Marzano L; Capuano A; Andreucci M; Balletta MM; Guida B; Tetta C;
    Am J Kidney Dis; 2002 Feb; 39(2):266-73. PubMed ID: 11840366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
    Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
    Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
    Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
    Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysis.
    Maia LP; Martins-Filho OA; Teixeira-Carvalho A; Speziali E; Vermhren R; Lira EF; Lima TA; Braga WS; Torres KL; Malheiro A
    J Med Virol; 2009 Jul; 81(7):1220-31. PubMed ID: 19475604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there any relationship between serum levels of interleukin-10 and atherosclerosis in hemodialysis patients?
    Seyrek N; Karayaylali I; Balal M; Paydas S; Aikimbaev K; Cetiner S; Seydaoglu G
    Scand J Urol Nephrol; 2005; 39(5):405-9. PubMed ID: 16257843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen.
    Selm SB
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1165-8. PubMed ID: 21060200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of hepatitis C infection in patients on hemodialysis: a multicenter study of northern part of Iran.
    Zamani F; Ameli M; Razmjou S; Shakeri R; Amiri A; Darvish R
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1169-71. PubMed ID: 21060201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory markers and hepatocyte growth factor in sustained hemodialysis hypotension.
    Lee CT; Hsu CY; Lam KK; Lin CR; Chen JB
    Artif Organs; 2005 Dec; 29(12):980-3. PubMed ID: 16305655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia.
    Shakeri A; Tabibi H; Hedayati M
    Hemodial Int; 2010 Oct; 14(4):498-504. PubMed ID: 20812958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for hepatitis C virus infection in patients on long-term hemodialysis.
    Khokhar N; Alam AY; Naz F; Mahmud SN
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):326-8. PubMed ID: 15924834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.